Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fortinet Inc (FTNT) vs Johnson & Johnson (JNJ) Price & Performance

Fortinet IncTrade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Fortinet Inc vs Johnson & Johnson — how do they compare? Fortinet Inc trades at $161.53 (market cap $118.78B), while Johnson & Johnson trades at $260.21 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 5.3× Fortinet Inc's market cap, and Johnson & Johnson pays a 2.06% dividend while Fortinet Inc pays none. Which is the better fit depends on your goals.

FTNTJNJ
Market Cap
$118.78B$626.09B
Sector
TechnologyHealth
52-Week High
$168.29$267.24
52-Week Low
$75.23$172.78
Enterprise Value
$115.21B$654.37B
Volume
6,156,228
Dividend Yield
2.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fortinet Inc

Fortinet (FTNT) trades at $164.09, down slightly by 0.07% today, with strong technical momentum showing bullish moving average signals. The company demonstrates robust fundamentals with revenue growing from $6.0B in 2024 to $6.8B in 2025 and net income reaching $1.85B. Recent Q2 2026 earnings beat expectations with $0.90 EPS versus $0.746 expected, continuing a pattern of strong quarterly performance. Analyst consensus remains positive with a $174.50 price target representing 6% upside potential from current levels.

Fortinet presents a compelling growth story with cybersecurity demand accelerating amid AI adoption, though elevated valuation metrics (P/E 57.2, P/S 16.08) require continued execution. Key risks include competitive pressures in the cybersecurity space and the stock's premium pricing relative to historical norms. The combination of strong earnings momentum, institutional support, and positive industry trends supports a constructive outlook for patient investors.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.

Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Fortinet Inc

Fortinet is a cybersecurity vendor that sells products, support, and services to small and midsize businesses, enterprises, and government entities. Its products include unified threat management appliances, firewalls, network security, and its security platform, Security Fabric. Services revenue is primarily from FortiGuard security subscriptions and FortiCare technical support. At the end of 2021, products were 38% of revenue and services were 62% of sales. The California-based company sells products worldwide.

Read more on FTNT

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ